XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Disaggregation of Revenues and Concentration Risk
 3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenues and Concentration Risk

7. Disaggregation of Revenues and Concentration Risk

 

The following table presents the percentage of consolidated revenues generated by unaffiliated customers that individually represent greater than ten percent of consolidated revenues:

 

   Three Months Ended 
   March 31, 
   2023   2022 
Pharma services - Company A   19%   14%
Pharma services - Company B   12%   -* 
Discontinued operations - DetermaRx   55%   65%

 

* Less than 10%

 

The following table presents the percentage of consolidated revenues by products or services classes:

 

   Three Months Ended 
   March 31, 
   2023   2022 
Pharma Services   42%   27%
Discontinuing operations   58%   73%
Total   100%   100%

 

The following table presents the percentage of consolidated revenues attributable to geographical locations:

 

   2023   2022 
   Three Months Ended 
   March 31, 
   2023   2022 
United States – Pharma Services   17%   17%
Outside of the United States – Pharma Services   25%   9%
Outside of the United States – Licensing   -%   -%
Discontinuing operations – Outside of the United States – Licensing   -%   -%
Discontinuing operations – United States – DetermaRx   58%   74%
Total   100%   100%